Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.

Baijun DongLiancheng FanYanqing WangChenfei ChiXiaowei MaRui WangWen CaiXiaoguang ShaoJiahua PanYinjie ZhuXun ShangguanZhixiang XinJianian HuShaowei XieXiaonan KangLixin ZhouWei Xue

Published in: The Prostate (2017)

We hypothesized that AA might not significantly lead to progression of NED of mCRPC in general. Furthermore, we found there was heterogeneity in changes of NED markers in different mCRPC patients during AA treatment. Serial CgA and NSE evaluation might help clinicians guide clinical treatment of mCRPC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
small cell lung cancer
peritoneal dialysis
hiv infected
patient reported outcomes
palliative care
rectal cancer
patient reported
locally advanced